insulin glargine
insulin glargine is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including Lantus, Insulin glargine U-300, LANTUS SOLOSTAR. Available dosage forms: injection, solution, powder.
Drug details
- Generic Name
- insulin glargine
- Brand Names
- Lantus, Insulin glargine U-300, LANTUS SOLOSTAR, Lantus Solostar, TOUJEO Max, TOUJEO, Insulin Glargine Solostar, Insulin glargine U-300 Max
- Application Number
- BLA021081
- Sponsor
- A-S Medication Solutions
- NDC Codes
- 17
- Dosage Forms
- INJECTION, SOLUTION, POWDER
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN GLARGINE
Indications and Usage
1 INDICATIONS AND USAGE BASAGLAR ® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. BASAGLAR ® is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use : Not recommended for treating diabetic ketoacidosis. ( 1 ) Limitations of Use BASAGLAR is not recommended for the treatment of diabetic ketoacidosis.